Cargando…
Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
We review the role of aspirin and clopidogrel for prevention of ischemic stroke and explore the concept of antiplatelet therapy resistance both from a laboratory and clinical perspective and genetic polymorphisms that might influence platelet reactivity with clopidogrel administration. Debates have...
Autores principales: | Gorelick, Philip B., Farooq, Muhammad U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725785/ https://www.ncbi.nlm.nih.gov/pubmed/23936730 http://dx.doi.org/10.1155/2013/727842 |
Ejemplares similares
-
Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021) -
Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023) -
Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022) -
Management of blood pressure in stroke
por: Gorelick, Philip B., et al.
Publicado: (2019) -
Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)